Cited by 162Diet, Metabolism, and DiseaseLiver Disease Diagnosis and TreatmentGut microbiota and health

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease

Spruss, Astrid, Bergheim, Ina·2009·The Journal of Nutritional Biochemistry

DOI 10.1016/j.jnutbio.2009.05.006

Open this paper in CoChat — free account

Abstract

Worldwide, not only the prevalence of obesity has increased dramatically throughout the last three decades but also the incidences of co-morbid conditions such as diabetes type 2 and liver disease have increased. The 'hepatic manifestation of the metabolic syndrome' is called nonalcoholic fatty liver disease (NAFLD) and comprises a wide spectrum of stages of liver disease ranging from simple steatosis to liver cirrhosis. NAFLD of different stages is found in approximately 30% of adults and approximately 20% in the US population. Not just a general overnutrition but also an elevated intake of certain macronutrients such as fat and carbohydrates and herein particularly fructose has been claimed to be risk factors for the development for NAFLD; however, the etiology of this disease is still unknown. The present review outlines some of the potential mechanisms associated with the development of NAFLD and fructose intake with a particular focus on the role of the intestinal barrier functions.

Integrity signals

Registry

Crossref · 10.1016/j.jnutbio.2009.05.006

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity
Bray, G. A., Nielsen, S. J., & Popkin, B. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.537 · Cited by 1,990
Fructose, weight gain, and the insulin resistance syndrome,,
Elliott, S. S., Keim, N. L., Stern, J. S., Teff, K. L., & Havel, P. J. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.911 · Cited by 1,031
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis
Brun, P., Castagliuolo, I., Leo, V. D., Buda, A., Pinzani, M., Palù, G., & Martines, D. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2006 · Cited by 880
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y. Y., McCall, S. J., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 862
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis
Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., & Cummins, A. G. (2001) · Gut · doi:10.1136/gut.48.2.206 · Cited by 836
Toll‐like receptor‐4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non‐alcoholic steatohepatitis
Rivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693
A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver
Yamashita, H., Takenoshita, M., Sakurai, M., Bruick, R. K., Henzel, W. J., Shillinglaw, W., Arnot, D., & Uyeda, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161284298 · Cited by 682
Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment
Gross, L. S., Li, L., Ford, E. S., & Liu, S. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.774 · Cited by 681
Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP
Lin, J. D., Yang, R., Tarr, P. T., Wu, P., Handschin, C., Li, S., Yang, W., Pei, L., Uldry, M., Tontonoz, P., et al. (2005) · Cell · doi:10.1016/j.cell.2004.11.043 · Cited by 626

Flagged first, then by citations

Show all 57 references

Sorted by citations

Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
“Role of intestinal permeability and probiotics in obesity and fatty liver disease The new concepts on the pathophysiology of obesity and associated metabolic diseases such as NAFLD and NASH, type 2 diabetes mellitus or cardiovascular diseases, stating that such pathologies are related to the intestinal barrier and the…”
Background
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S. A., Nadeau, K. J., Cree‐Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 993
“This is likely to be responsible for the increased gut permeability that has been observed with fructose ingestion.(88,89) Indeed, studies by”
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M. C. D. O., Saraiva, J., Chacra, A., Bianco, H. T., Neto, A. A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A. C., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 690
Molecular pathways of nonalcoholic fatty liver disease development and progression
Bessone, F., Razori, M. V., & Roma, M. G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 664
'Gut health': a new objective in medicine?
Bischoff, S. C. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-24 · Cited by 338
“In recent publications, high-fat as well as high-fructose diets have been shown to disturb the GI barrier and, in this way, to induce fatty liver disease and subclinical inflammatory conditions associated with metabolic disturbances [35,89,90].”
In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
Kanuri, G., & Bergheim, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140611963 · Cited by 293
“, US, Japan, Israel and Germany) suggest that a shift in dietary patterns towards a sugar rich diet may also be risk factor for the development of NAFLD in humans (for overview see [60,61]).”
Background
Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice
Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., & Bischoff, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080169 · Cited by 292
“Yet, it is unknown, if changes within the intestinal microbiota, which have been reported under high-fructose diet [18] may be related to the pathogenesis of liver steatosis.”
BackgroundSelf-citation
Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol‐Inducible Cytochrome P450‐2E1–Mediated Oxidative and Nitrative Stress
Cho, Y., Kim, D., Seo, W., Gao, B., Yoo, S., & Song, B. (2019) · Hepatology · doi:10.1002/hep.30652 · Cited by 266
“(2) Recent studies suggest that overconsumption of Western-style high-fat diet and/or Abbreviations: 3-NT, 3-nitrotyrosine; Acy-His3, acetyl-histone-3; AFLD, alcoholic fatty liver disease; AJ, adherent junction; ALT, alanine aminotransferase; AMPK, adenosine 5′ monophosphate-activated protein kinase; Bcl-2, B-cell lym…”
BackgroundInfluential
Reactive Oxygen Species-Induced TXNIP Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through NLRP3 Inflammasome Activation
Zhang, X., Zhang, J.-H., Chen, X.-Y., Hu, Q., Wang, M., Jin, R., Zhang, Q., Wang, W., Wang, R., Kang, L.-L., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5868 · Cited by 240
“In that respect, the high fructose diet in rats has made it possible to investigate hepatopathological changes that also occur in humans with NAFLD (46).”
Background
Metabolic drivers of non-alcoholic fatty liver disease
Bence, K. K., & Birnbaum, M. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101143 · Cited by 230
Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota
Cui, Y., Wang, Q., Chang, R., Zhou, X., & Xu, C. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b00080 · Cited by 220
Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
Lambertz, J., Weiskirchen, S., Landert, S., & Weiskirchen, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01159 · Cited by 195
Gut microbiome, endocrine control of gut barrier function and metabolic diseases
Régnier, M., Hul, M. V., Knauf, C., & Cani, P. D. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0473 · Cited by 183
“…endotoxaemia) and transcriptional activation of bacterial toll-like receptors, the authors proposed that fructose in combination with fat altered the gut barrier, leading to the translocation of bacterial products and thereby promoting hepatic inflammation (Spruss & Bergheim 2009, Ochoa et al.”
Background
Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
Hrncir, T., Hrncirova, L., Kverka, M., Hromádka, R., Machova, V., Trckova, E., Kostovcikova, K., Králíčková, P., Krejsek, J., & Tlaskalová‐Hogenová, H. (2021) · Microorganisms · doi:10.3390/microorganisms9050957 · Cited by 183
“For example, chronic fructose consumption is associated with tight junction disruption [53] and increased intestinal permeability [54,55].”
Background
A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
Temple, J., Cordero, P., Li, J., Nguyen, V., & Oben, J. A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060947 · Cited by 179
“It may also promote liver injury in NAFLD by causing bacterial overgrowth and increased intestinal permeability, precipitating endotoxemia and subsequent initiation of inflammation but this has yet to be proven [142,143].”
Background
Non-alcoholic fatty liver disease: A sign of systemic disease
Reccia, I., Jayant, K., Akladios, C. Y., Virdis, F., Pai, M., Habib, N., & Spalding, D. R. C. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.011 · Cited by 171
Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function
Spruss, A., Kanuri, G., Stahl, C., Bischoff, S. C., & Bergheim, I. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.75 · Cited by 168
Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
Mokhtari, Z., Gibson, D. L., & Hekmatdoost, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013151 · Cited by 170
“The chronic intake of fructose is associated with bacterial overgrowth, which causes increases in endotoxins in the portal vein, development of inflammatory responses in the liver, and insulin resistance in hepatocytes, resulting in increased hepatic lipid accumulation (140, 141).”
Background
Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates
Ullah, R., Rauf, N., Nabi, G., Ullah, H., Shen, Y., Zhou, Y., & Fu, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30121 · Cited by 162
“Fructose interacts with transcriptional factors and affects the gene expression involved in glycolysis and lipogenesis [6].”
Background
The etiology of glomerulonephritis: roles of infection and autoimmunity
Couser, W. G., & Johnson, R. J. (2014) · Kidney International · doi:10.1038/ki.2014.49 · Cited by 151
High fructose feeding induces copper deficiency in Sprague–Dawley rats: A novel mechanism for obesity related fatty liver
Song, M., Schuschke, D. A., Zhou, Z., Chen, T., Pierce, W. M. J., Wang, R., Johnson, W. T., & McClain, C. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.030 · Cited by 143
“The increased consumption of fructose temporally parallels the increased prevalence of obesity and the metabolic syndrome in the United States and worldwide [1,2].”
The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
Ji, Y. S., Yin, Y., Sun, L., & Zhang, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093066 · Cited by 132
Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers
Russo, F., Linsalata, M., Clemente, C., Chiloiro, M., Orlando, A., Marconi, E., Chimienti, G., & Riezzo, G. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.09.010 · Cited by 126
“[5] Spruss A, Bergheim I.”
Background
Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases
Shang, M., & Sun, J. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666161202150008 · Cited by 127
“Bacterial overgrowth, intestinal barrier function impairment and an increased pathogen toxicity are involved in the early phases of liver diseases, such as steatosis, steatohepatitis or liver injury [78].”
Background
Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications
Song, B.-J., Akbar, M., Abdelmegeed, M. A., Byun, K., Lee, B., Yoon, S. K., & Hardwick, J. P. (2014) · Redox Biology · doi:10.1016/j.redox.2014.10.004 · Cited by 123
Lactobacillus casei Shirota protects from fructose-induced liver steatosis: A mouse model
Wagnerberger, S., Spruss, A., Kanuri, G., Stahl, C., Schröder, M., Vetter, W., Bischoff, S. C., & Bergheim, I. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.01.014 · Cited by 123
“steatosis and steatohepatitis) bacterial overgrowth, impaired intestinal barrier function and an increased translocation of bacterial endotoxins may be involved (for review see [2]).”
Background
Toll-like receptors 1–9 are elevated in livers with fructose-induced hepatic steatosis
Wagnerberger, S., Spruss, A., Kanuri, G., Volynets, V., Stahl, C., Bischoff, S. C., & Bergheim, I. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004983 · Cited by 125
Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice
Kanuri, G., Spruss, A., Wagnerberger, S., Bischoff, S. C., & Bergheim, I. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.007 · Cited by 112
“[5]).”
Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children
Stevens, L. J., Kuczek, T., Burgess, J. R., Stochelski, M. A., Arnold, L. E., & Galland, L. (2013) · Nutrition Reviews · doi:10.1111/nure.12023 · Cited by 114
Nonalcoholic fatty liver disease – current status and future directions
Demir, M., Lang, S., & Steffen, H. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12291 · Cited by 105
Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease
Jegatheesan, P., Beutheu, S., Ventura, G., Sarfati, G., Nubret, E., Kapel, N., Waligora‐Dupriet, A., Bergheim, I., Cynober, L., & Bandt, J. P. D. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.01.021 · Cited by 102
“In the gut, chronic fructose feeding has been demonstrated to induce increased intestinal permeability, through the loss of occludin expression, and increased endotoxin translocation [3].”
Background
Polyphenol-Rich Loquat Fruit Extract Prevents Fructose-Induced Nonalcoholic Fatty Liver Disease by Modulating Glycometabolism, Lipometabolism, Oxidative Stress, Inflammation, Intestinal Barrier, and Gut Microbiota in Mice
Li, W., Yang, H., Zhao, Q., Wang, X., Zhang, J., & Zhao, X. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02523 · Cited by 100
Gut Microbiota and Lifestyle Interventions in NAFLD
Houghton, D., Stewart, C. J., Day, C. P., & Trenell, M. I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040447 · Cited by 99
“Furthermore, probiotics have been shown to be effective at improving epithelial barrier integrity [178] and stimulating the host immune response [179,180].”
Background
Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats
Jegatheesan, P., Beutheu, S., Freese, K., Waligora‐Dupriet, A., Nubret, E., Butel, M. O., Bergheim, I., & Bandt, J. P. D. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516001793 · Cited by 95
Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice
Ritze, Y., Bárdos, G., Hubert, A., Böhle, M., & Bischoff, S. C. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000440 · Cited by 90
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
Akhtar, D. H., Iqbal, U., Vazquez‐Montesino, L. M., Dennis, B. B., & Ahmed, A. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2019.00028 · Cited by 89
Female Mice Are More Susceptible to Nonalcoholic Fatty Liver Disease: Sex-Specific Regulation of the Hepatic AMP-Activated Protein Kinase-Plasminogen Activator Inhibitor 1 Cascade, but Not the Hepatic Endotoxin Response
Spruss, A., Henkel, J., Kanuri, G., Blank, D., Püschel, G., Bischoff, S., & Bergheim, I. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00223 · Cited by 83
“For instance, the chronic feeding of fructose produces pathological changes in the liver and also in the intestine and adipose tissue that resemble many of the early alterations (for example, steatosis and insulin resistance) that also occur in humans with NAFLD (14).”
Background
Protective effects of matrine against progression of high-fructose diet-induced steatohepatitis by enhancing antioxidant and anti-inflammatory defences involving Nrf2 translocation
Zhang, H.-F., Shi, L., Song, G., Cai, Z.-G., Wang, C., & An, R.-J. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.12.043 · Cited by 82
The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
Federico, A., Rosato, V., Masarone, M., Torre, P., Dallio, M., Romeo, M., & Persico, M. (2021) · Nutrients · doi:10.3390/nu13041314 · Cited by 82
“Intestinal Absorption of Fructose and Microbial Fructose Metabolism in NAFLD Regarding fructose metabolism triggering NAFLD, it is well established that intestinal absorption may regulate the load of fructose reaching the liver and microbial dysbiosis, increasing endotoxin levels, intestinal permeability, and progress…”
Background
Bifidobacterium adolescentis protects from the development of nonalcoholic steatohepatitis in a mouse model
Reichold, A., Brenner, S. A., Spruss, A., Förster‐Fromme, K., Bergheim, I., & Bischoff, S. C. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.09.011 · Cited by 82
“There is cumulative evidence that, in the early phases of NAFLD, bacterial overgrowth in the intestine, impaired intestinal barrier function and an increased translocation of bacterial endotoxin may be involved in the development of the liver damage (reviewed in [13]).”
Background
Role of the Inducible Nitric Oxide Synthase in the Onset of Fructose-Induced Steatosis in Mice
Spruss, A., Kanuri, G., Uebel, K., Bischoff, S. C., & Bergheim, I. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3263 · Cited by 79
“Increased carbohydrate and in particular fructose intake has been discussed in recent years to be one of the key factors in the development of obesity, metabolic syndrome ( e.g. , insulin resistance and dyslipidemia), and NAFLD [for over-FIG view, also see (36)].”
Selenium-containing polysaccharides from Ziyang green tea ameliorate high-fructose diet induced insulin resistance and hepatic oxidative stress in mice
Ren, D., Hu, Y., Luo, Y., & Yang, X. (2015) · Food & Function · doi:10.1039/c5fo00557d · Cited by 74
Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments
Scorletti, E., Calder, P. C., & Byrne, C. D. (2011) · Endocrine · doi:10.1007/s12020-011-9530-x · Cited by 75
“Chronic high intake of fructose may cause overgrowth of intestinal bacteria and increase intestinal permeability, leading to a translocation of bacterial endotoxin into the bloodstream, which in turn activates Kupffer cells, ultimately causing inflammation and accumulation of fat in the liver [28].”
Background
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
Biolato, M., Manca, F., Marrone, G., Cefalo, C., Racco, S., Miggiano, G. A. D., Valenza, V., Gasbarrini, A., Miele, L., & Grieco, A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i4.509 · Cited by 78
Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern
Nier, A., Brandt, A., Conzelmann, I., Özel, Y., & Bergheim, I. (2018) · Nutrients · doi:10.3390/nu10091329 · Cited by 69
Sugar-sweetened beverages and cardio-metabolic disease risks
Richelsen, B. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328361c53e · Cited by 68
“Another mechanism has recently been suggested wherein intake of fructose may affect the bacteria in the gut (microbiota) which again may affect the permeability of the gut and enhanced uptake of, that is, endotoxins and thereby increase the risk of metabolic syndrome [34].”
Background
Amounts of Artificial Food Dyes and Added Sugars in Foods and Sweets Commonly Consumed by Children
Stevens, L. J., Burgess, J. R., Stochelski, M. A., & Kuczek, T. (2014) · Clinical Pediatrics · doi:10.1177/0009922814530803 · Cited by 65
Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis
Vergani, L. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170518101334 · Cited by 64
Dietary fructose causes defective insulin signalling and ceramide accumulation in the liver that can be reversed by gut microbiota modulation
Crescenzo, R., Mazzoli, A., Di Luccia, B., Bianco, F., Cancelliere, R., Cigliano, L., Liverini, G., Baccigalupi, L., & Iossa, S. (2017) · Food & Nutrition Research · doi:10.1080/16546628.2017.1331657 · Cited by 63
“Our present result of a decreased content of the tightjunction protein occludin in the ileum of fructose-fed rats suggests that there is an increased gut permeability in these rats, thus allowing for higher translocation of LPS into the portal blood, in line with a previous proposal [35].”
Result
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms
Mandala, A., Janssen, R. C., Palle, S. K., Short, K. R., & Friedman, J. E. (2020) · Nutrients · doi:10.3390/nu12103166 · Cited by 61
“, Mediterranean diet) [94,95] and positive relations of sugar (fructose in particular [96,97]), fat [98,99], and total energy intake [100] with serum endotoxin.”
Background
Study on urine metabolic profiling and pathogenesis of hyperlipidemia
Liu, Y., Zhu, L., Song, Y., Liu, Y., Zhao, H., Liu, Y. S., Zhang, T., Yuan, Y., Cai, X., Wang, S., et al. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.05.001 · Cited by 56
Hypoglycemic and hepatoprotective effects of polysaccharides from Artemisia sphaerocephala Krasch seeds
Ren, D., Zhao, Y., Nie, Y., Yang, N., & Yang, X. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.05.064 · Cited by 56
Emodin Prevents Intrahepatic Fat Accumulation, Inflammation and Redox Status Imbalance During Diet-Induced Hepatosteatosis in Rats
Alisi, A., Pastore, A., Ceccarelli, S., Panera, N., Gnani, D., Bruscalupi, G., Massimi, M., Tozzi, G., Piemonte, F., & Nobili, V. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13022276 · Cited by 54
“In conclusion, all these findings suggest the use of emodin, not only as a potential preventive agent in NAFLD diet-induced and a promising agent for hampering the progression to NASH, but also as a natural coadjuvant of the more classical antioxidant therapy.”
BackgroundInfluential
Dietary sugars: their detection by the gut–brain axis and their peripheral and central effects in health and diseases
Ochoa, M., Lallès, J. P., Malbert, C., & Val‐Laillet, D. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0776-y · Cited by 54
“Consistent evidence has demonstrated the implication of fructose or HFCS in the development of NAFLD in several animal models [17, 33–38].”
Lower Fructose Intake May Help Protect Against Development of Nonalcoholic Fatty Liver in Adolescents With Obesity
O’Sullivan, T. A., Oddy, W. H., Bremner, A., Sherriff, J. L., Ayonrinde, O. T., Olynyk, J. K., Beilin, L. J., Mori, T. A., & Adams, L. A. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000267 · Cited by 51
Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice
Volynets, V., Spruss, A., Kanuri, G., Wagnerberger, S., Bischoff, S. C., & Bergheim, I. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m007179 · Cited by 51
Hepatoprotective Effects of Sophoricoside against Fructose‐Induced Liver Injury via Regulating Lipid Metabolism, Oxidation, and Inflammation in Mice
Li, W., & Lu, Y. (2018) · Journal of Food Science · doi:10.1111/1750-3841.14047 · Cited by 51
The impact of dietary fructose on gut permeability, microbiota, abdominal adiposity, insulin signaling and reproductive function
Güney, C., Bal, N. B., & Akar, F. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18896 · Cited by 53
“TLRs can be activated by microbial pathogen-associated molecules such as endotoxin that occurs in the cell membrane of gram-negative bacteria and plays an influential role in fructose-induced endotoxemia [42].”
Background
Black Sesame Seeds Ethanol Extract Ameliorates Hepatic Lipid Accumulation, Oxidative Stress, and Insulin Resistance in Fructose-Induced Nonalcoholic Fatty Liver Disease
Yang, Y., Wang, J., Zhang, Y., Li, J., & Sun, W. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b04210 · Cited by 47
Possible Links between Intestinal Permeablity and Food Processing: A Potential Therapeutic Niche for Glutamine
Rapin, J. R., & Wiernsperger, N. F. (2010) · Clinics · doi:10.1590/s1807-59322010000600012 · Cited by 46
The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease
Feldman, A., Aigner, E. S., Weghuber, D., & Paulmichl, K. (2015) · BioMed Research International · doi:10.1155/2015/287401 · Cited by 45
“In addition, an excessive consumption of fructose, which parallels the increasing prevalence of obesity worldwide, is a wellrecognized risk factor for NAFLD [72].”
Lactoferrin Dampens High-Fructose Corn Syrup-Induced Hepatic Manifestations of the Metabolic Syndrome in a Murine Model
Li, Y.-C., & Hsieh, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097341 · Cited by 45
“HFSC stimulates overgrowth of intestinal microbiota, increasing intestinal permeability and leading to chronic inflammation [32].”
Background
High Fructose Intake During Pregnancy in Rats Influences the Maternal Microbiome and Gut Development in the Offspring
Astbury, S., Song, A., Zhou, M., Nielsen, B., Hoedl, A., Willing, B. P., Symonds, M. E., & Bell, R. C. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00203 · Cited by 44
“There is some evidence to support both hypotheses that fructose is known to adversely affect intestinal permeability (Spruss and Bergheim, 2009) and disruption of the maternal microbiota can lead to altered offspring gut development (Fåk et al.”
Background
Lentil (Lens culinaris Medikus) Diet Affects the Gut Microbiome and Obesity Markers in Rat
Siva, N., Johnson, C. R., Richard, V., Jesch, E. D., Whiteside, W. S., Abood, A., Thavarajah, P., Duckett, S. K., & Thavarajah, D. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03254 · Cited by 46
In vitro micro-physiological models for translational immunology
Ramadan, Q., & Gijs, M. A. M. (2015) · Lab on a Chip · doi:10.1039/c4lc01271b · Cited by 41
Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis
Sellmann, C., Jin, C. J., Degen, C., Bandt, J. P. D., & Bergheim, I. (2015) · Journal of Nutrition · doi:10.3945/jn.115.215517 · Cited by 40
Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response
Song, M., Chen, T., Prough, R. A., Cave, M. C., & McClain, C. J. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12994 · Cited by 40
“KC activation is a key event contributing to the alcoholic liver injury as well as NAFLD (Miura et al., 2012; Spruss et al., 2009; Thurman, 1998).”
Influential
Enhancing the hepatic protective effect of genistein by oral administration with stachyose in mice with chronic high fructose diet consumption
Li, W., Li, K., Han, X., Huang, D., Lu, Y., & Yang, X. (2016) · Food & Function · doi:10.1039/c6fo00038j · Cited by 39
Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis
Le, T., & Loomba, R. S. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/s0973-6883(12)60104-2 · Cited by 41
High Rates of Fructose Malabsorption Are Associated with Reduced Liver Fat in Obese African Americans
Walker, R. W., Lê, K., Davis, J., Alderete, T. L., Cherry, R. N., Lebel, S., & Goran, M. I. (2012) · Journal of the American College of Nutrition · doi:10.1080/07315724.2012.10720445 · Cited by 38
“Fructose metabolism is not rate-limited by the availability of phosphofructokinase, as is the metabolism of glucose [24]; therefore, fructose can more readily enter the gluconeogenic and glycogen synthesis pathways.”
Background
Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long‐chain n‐3 PUFA
Delarue, J., & Lallès, J. P. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500346 · Cited by 37
“HFr diets favor bacterial overgrowth and associated intestinal barrier dysfunction in animals [70], but little is known on specific microbial changes.”
Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice
Zhou, X., Zhang, X., Niu, D., Zhang, S., Wang, H., Zhang, X., Nan, F., Jiang, S., & Wang, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-33806-8 · Cited by 39
Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis
Cheng, W., Li, S., Lee, T.-I., Lee, T., Chung, C., Kao, Y., & Chen, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9070728 · Cited by 41
Modest fructose beverage intake causes liver injury and fat accumulation in marginal copper deficient rats
Song, M., Schuschke, D. A., Zhou, Z., Chen, T., Shi, X., Zhang, J., Zhang, X., Pierce, W. M. J., Johnson, W. T., Vos, M. B., et al. (2013) · Obesity · doi:10.1002/oby.20380 · Cited by 35
“The increased consumption of fructose temporally parallels the increased prevalence of obesity and the metabolic syndrome in USA and worldwide (4,5).”
Background
Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification
Panasevich, M. R., Peppler, W. T., Oerther, D. B., Wright, D. C., & Rector, R. S. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00012.2017 · Cited by 35
“LPS elicits a signaling cascade known to promote NASH (33, 72, 160, 196).”
Background
Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease
Ghaemi, A., Hosseini, N., Osati, S., Naghizadeh, M. M., Dehghan, A., Ehrampoush, E., Honarvar, B., & Homayounfar, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-23192-x · Cited by 35
Dietary protein restriction induces steatohepatitis and alters leptin/signal transducers and activators of transcription 3 signaling in lactating rats
Kwon, D., Kang, W., Nam, Y. S., Lee, M. S., Lee, I. Y., Kim, H. J., Rajasekar, P., Lee, J.-H., & Baik, M. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.04.002 · Cited by 32
“The quantity and types of carbohydrate in the diet have been suggested to influence on hepatic steatosis and body fat accumulation [24,25].”
Background
A High-Fat, High-Fructose Diet Accelerates Nutrient Absorption and Impairs Net Hepatic Glucose Uptake in Response to a Mixed Meal in Partially Pancreatectomized Dogs,
Coate, K. C., Kraft, G., Lautz, M., Smith, M. S., Neal, D. W., & Cherrington, A. D. (2011) · Journal of Nutrition · doi:10.3945/jn.111.145359 · Cited by 30
Hemp sprout-derived exosome-like nanovesicles as hepatoprotective agents attenuate liver fibrosis
Kim, J.-S., Eom, J., Kim, H., Ko, J., Hong, E., Kim, M.-N., Kim, J., Kim, D., Kwon, H., & Cho, Y. (2024) · Biomaterials Science · doi:10.1039/d4bm00812j · Cited by 29
Consumption of post-fermented Jing-Wei Fuzhuan brick tea alleviates liver dysfunction and intestinal microbiota dysbiosis in high fructose diet-fed mice
Zhang, X.-N., Wu, Q., Zhao, Y., Aimy, A., & Yang, X.-B. (2019) · RSC Advances · doi:10.1039/c9ra02473e · Cited by 22
Maternal fructose induces gender-dependent changes in both LXRα promoter methylation and cholesterol metabolism in progeny
Rodrigo, S., Fauste, E., de la Cuesta, M., Rodríguez, L., Álvarez‐Millán, J. J., Panadero, M. I., Otero, P., & Bocos, C. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.08.011 · Cited by 29
“In fact, dietary fructose has been reported to affect the intestinal barrier [54], and carbohydrate consumption has been shown to influence folate absorption and bacterial folate production in the small intestine [55].”
Background
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
Abdelhameed, F., Mustafa, A., Kite, C., Lagojda, L., Dallaway, A., Than, N. N., Kassi, E. N., Kyrou, I., & Randeva, H. S. (2025) · Livers · doi:10.3390/livers5010011 · Cited by 35
Effect of chrysin on changes in intestinal environment and microbiome induced by fructose-feeding in rats
Andrade, N., Marques, C., Andrade, S., Silva, C., Rodrigues, I., Guardão, L., Guimarães, J. T., Keating, E., Calhau, C., & Martel, F. (2019) · Food & Function · doi:10.1039/c9fo01142k · Cited by 29
Fructose-induced stress signaling in the liver involves methylglyoxal
Wei, Y., Wang, D., Moran, G., Estrada, A. L., & Pagliassotti, M. J. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-32 · Cited by 27
“Recent studies have also demonstrated that fructose consumption in beverages or water can lead to accumulation of visceral fat and changes in intestinal barrier function [36,37].”
A Sweet Connection? Fructose’s Role in Hepatocellular Carcinoma
Dewdney, B., Roberts, A. A., Qiao, L., George, J., & Hebbard, L. (2020) · Biomolecules · doi:10.3390/biom10040496 · Cited by 29
“It has been well established through several animal and human studies that small intestine microbiome dysbiosis is associated with NAFLD/NASH development, as demonstrated by increased endotoxin levels and intestinal permeability [58].”
Background
Nonalcoholic Fatty Liver Disease: A Nutritional Approach
Çolak, Y., Tuncer, İ., Şenateş, E., Öztürk, O., Doğanay, H. L., & Yilmaz, Y. N. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0145 · Cited by 26
Chronic intake of high dietary sucrose induces sexually dimorphic metabolic adaptations in mouse liver and adipose tissue
Stephenson, E. J., Stayton, A., Sethuraman, A., Rao, P. K., Meyer, A. C., Gomes, C., Mulcahy, M. C., McAllan, L., Puchowicz, M. A., Pierre, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33840-6 · Cited by 18
Clinical physiology of NAFLD: a critical overview of pathogenesis and treatment
Lonardo, A., Caldwell, S. H., & Loria, P. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.5 · Cited by 25
The Impact of Gut Microbiome on Maternal Fructose Intake-Induced Developmental Programming of Adult Disease
Hsu, C., Yu, H., Chan, J. Y. H., Wu, K. L. H., Lee, W., & Tain, Y. (2022) · Nutrients · doi:10.3390/nu14051031 · Cited by 23
“Chronic consumption of fructose is accompanied with a loss of intestinal tight junction proteins, resulting in elevated translocation of endotoxin [34].”
Background
Comparison of Three Different Diet-Induced Non Alcoholic Fatty Liver Disease Protocols in Rats: A Pilot Study
Shojaei‐Zarghani, S., Soraya, H., Zarei, L., & Alizadeh, M. (2016) · Pharmaceutical Sciences · doi:10.15171/ps.2016.03 · Cited by 23
Differential capability of metabolic substrates to promote hepatocellular lipid accumulation
Hoang, N. A., Richter, F., Schubert, M., Lorkowski, S., Klotz, L., & Steinbrenner, H. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1847-2 · Cited by 25
4-Hydroxynonenal (HNE) and hepatic injury related to chronic oxidative stress
Bekyarova, G. Y., Tzaneva, M. A., Bratoeva, K. Z., Иванова, И., Kotzev, A. I., Hristova, M., Krastev, D. S., Kindekov, I., & Mileva, M. M. (2019) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2019.1674690 · Cited by 20
“hepatocyte apoptosis in the steatotic liver [67,68].”
Are fructophilic lactic acid bacteria (FLAB) beneficial to humans?
Dicks, L. M. T., & Endo, A. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0044 · Cited by 19
Elicited soybean extract attenuates proinflammatory cytokines expression by modulating TLR3/TLR4 activation in high−fat, high−fructose diet mice
Atho’illah, M. F., Safitri, Y. D., Nur’aini, F. D., Widyarti, S., Tsuboi, H., & Rifa’i, M. (2021) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2021.01.003 · Cited by 18
“Those DAMPs are increased by HFFD [7,8].”
Effect of Oral Administration of Weissella confusa on Fecal and Plasma Ethanol Concentrations, Lipids and Glucose Metabolism in Wistar Rats Fed High Fructose and Fat Diet
Elshaghabee, F. M. F., Ghadimi, D., Habermann, D., de Vrese, M., Bockelmann, W., Kaatsch, H., Heller, K. J., & Schrezenmeir, J. (2020) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s254195 · Cited by 18
Polysaccharides from Tumorous stem mustard prevented high fructose diet-induced non-alcoholic fatty liver disease by regulating gut microbiota, hepatic lipid metabolism, and the AKT/FOXO1/MAPK signaling pathway
Li, C., Li, W., Yang, H., Mi, Z., Tan, S., & Lei, X. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105448 · Cited by 17
Altered Hepatic Gene Expression Profiles Associated with Improved Fatty Liver, Insulin Resistance, and Intestinal Permeability after Hydroxypropyl Methylcellulose (HPMC) Supplementation in Diet-Induced Obese Mice
Kim, H., Bartley, G. E., Young, S. A., Seo, K., & YOKOYAMA, W. H. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf400545w · Cited by 18
Intestinal Trefoil Factor 3 Alleviates the Intestinal Barrier Function Through Reducing the Expression of TLR4 in Rats with Nonalcoholic Steatohepatitis
Wang, Y., Liang, K., & Kong, W.-Z. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.03.004 · Cited by 17

Authors: Spruss, A., & Bergheim, I.
Affiliations: University of Hohenheim (DE)
Corresponding author: Bergheim, Ina
ORCID: Bergheim, Ina
Venue: The Journal of Nutritional Biochemistry
Publisher: Elsevier BV
Published: 2009-09
Volume: 20
Issue: 9
Pages: 657-662
ISSN: 0955-2863 (ISSN-L)
DOI: 10.1016/j.jnutbio.2009.05.006
OpenAlex: W2088617983
Cited by: 162
References: 57
Citations by year: 2026: 5 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 7 · 2021: 7 · 2020: 10 · 2019: 20 · 2018: 14 · 2017: 11 · 2016: 8 · 2015: 11 · 2014: 14 · 2013: 11 · 2012: 12
FWCI: 1.30
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Journal of Nutritional Biochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft (BE2376/4-1)
Bundesministerium für Bildung und Forschung (0315084)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: non-alcoholic fatty liver disease, dietary fructose, intestinal barrier, metabolic syndrome, hepatic steatosis, liver cirrhosis, obesity, type 2 diabetes, fructose consumption, pathogenesis
MeSH terms: Animals, Dietary Carbohydrates, Fatty Liver, Fructose, Glucose, Humans, Intestinal Mucosa, Liver, Risk Factors, Transcription, Genetic, Dietary Sucrose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks